A US-based start-up biotech with a European HQ in Switzerland was preparing for its first launch in Europe. It did not have supply chain capabilities in Europe, and it needed support to design the supply chain and prepare it for commercialization. Our team designed and built an outsourced supply chain in Europe with capabilities for the EU and ex-EU geographies without commercial infrastructure. We developed a strategy mapping the financial and physical product flow options, including cost impacts. We also outlined the “last mile” options across markets, including hospital vs. retail and the potential use of infusion centers and home care. Finally, we led selection of a 3PL partner to support pan-European distribution, including order-to-cash.